Join the club for FREE to access the whole archive and other member benefits.

Investments News

Chugai, Gero ink $250m deal to target ageing

FierceBiotech - 07-Jul-2025

Gero’s AI will uncover ageing targets; Chugai will develop antibody drugs to treat related diseases

Read more...

China’s brain chips break new ground

Nature - 04-Jul-2025

BCIs in China help paralysed users control devices, play games, and speak Mandarin in real time

Read more...

Calico taps Mabwell’s anti-ageing antibody in $596m licensing deal

FierceBiotech - 26-Jun-2025

Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China

Read more...

DNA reborn: engineering life from scratch

BBC - 26-Jun-2025

UK project aims to build human DNA from scratch, raising hopes for cures—and ethical concerns

Read more...

Outsee raises 1.8m for AI genomics in drug discovery

Longevity Technology - 25-Jun-2025

Nomaly uses AI to decode disease from genomes, enabling precision medicine with small datasets

Read more...

Robot surgeons for eyes: ForSight aims to revolutionize cataract surgery

Forbes - 24-Jun-2025

ForSight’s $125M boost powers eye-surgery robot tested in 300 pig-eye trials, human ops next

Read more...

Infinity Bio raises $8m to decode the antibody reactome

Longevity Technology - 24-Jun-2025

Tech screens 1,000s of antibodies per assay; links chronic inflammation to faster ageing

Read more...

Cidara’s new flu drug shows strong protection in adults

BioPharma Dive - 23-Jun-2025

It may be a potential one-time seasonal alternative to vaccines without serious side effects

Read more...

Parallel Bio raises $21m to replace animal testing with human immune organoids

Longevity Technology - 17-Jun-2025

New platform aims to cut drug discovery by $2B and 9 years using lab-grown human immune models

Read more...

Juvena strikes $650m deal with lilly to tackle obesity

Longevity Technology - 11-Jun-2025

AI-driven protein therapies aim to boost muscle health and metabolism alongside weight loss

Read more...

Splicebio raises $135m to advance gene therapy for eye disease

FierceBiotech - 11-Jun-2025

SB-007 enters phase 1/2 trials to restore vision in Stargardt disease using novel splicing tech

Read more...

University spin-out Astratus unveils breakthrough in antibiotic testing

University of Reading - 10-Jun-2025

New tech delivers same-day results to improve prescriptions and curb rising antimicrobial resistance

Read more...

AI-driven leap: Juvenescence expands R&D capabilities with Ro5 acquisition

Longevity Technology - 05-Jun-2025

Ro5’s AI platform boosts Juvenescence’s age-related drug pipeline and fuels UAE healthtech push

Read more...

AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost

Longevity Technology - 30-May-2025

Biotech firm uses AI and robotics to test drugs on real human tissues, not animals

Read more...

Magnitude Biosciences secures funding to boost AI-powered drug discovery

BusinessLive - 29-May-2025

Biotech firm to create skilled jobs as it scales innovative platform for healthier ageing therapies

Read more...

Neuralink raised $600 million, reaching a $9 billion valuation

Longevity Technology - 28-May-2025

The company is still in early stages but attracting strong investor interest

Read more...

Maxwell’s AI platform drives revenue growth through health innovation

Live Forever Club - 27-May-2025

India partnerships and FDA progress boost future income

Read more...

Boundless bio cuts staff and rethinks strategy after lead drug fails in early trials

FierceBiotech - 27-May-2025

Biotech pivots to drug combo after monotherapy safety and efficacy setbacks

Read more...

Starfish neuroscience unveils plans for tiny, wireless brain chip

The Verge - 24-May-2025

Valve CEO’s BCI firm builds battery-free chip to interact with multiple brain regions

Read more...

Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition

Longevity Technology - 23-May-2025

Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy

Read more...

Tomorrow.Bio raises 5m to bring cryonics and life-after-death hopes to the U.S.

EU-Startups - 22-May-2025

Berlin startup freezes bodies, hoping for future revival

Read more...

UK biotech Juvenescence secures over $150m to develop therapies

Endpoints News - 21-May-2025

Juvenescence expands pipeline and UAE presence with new funding to tackle age-related diseases

Read more...

23andMe’s fall from fame ends in Regeneron takeover

BBC - 19-May-2025

Regeneron buys 23andMe for $256M, pledges to protect user data and boost drug discovery

Read more...

AI startup Somite raises $47m to revolutionize stem cell therapy

Longevity Technology - 16-May-2025

Somite AI uses DeltaStem to speed up and scale stem cell engineering

Read more...

The billionaire blind spot: why longevity science is being overlooked

NFX - 15-May-2025

Unlocking ageing science could add decades of life—but funding is the missing link

Read more...

BrightFocus Foundation fuels early research on aging diseases with $13m grants

Longevity Technology - 13-May-2025

Private funding supports global scientists tackling Alzheimer’s, vision loss, and glaucoma

Read more...

Rewriting the cell's code: HAYA’s mission to transform genomic medicine

Longevity Technology - 12-May-2025

Biotech startup raises $65M to develop RNA therapies that reprogram disease-driving cell states

Read more...

Xprize longevity contest narrows field to 40 semi-finalists

The Guardian - 11-May-2025

Drawn from over 1,000 global contenders, the selected teams are one step closer to the $101M prize

Read more...

Hundred health acquires BellSant to supercharge AI longevity platform strapline:

Longevity Technology - 08-May-2025

AI-driven health platform gears up for launch with cutting-edge longevity data

Read more...

NewLimit secures $130m to accelerate epigenetic reprogramming for longevity

Longevity Technology - 06-May-2025

The biotech company aims to target the root causes of ageing to develop therapies to extend lifespan

Read more...

Lilly bets big on AI-discovered ALS drug in $415m deal

FierceBiotech - 06-May-2025

AI-powered therapy offers new hope for ALS as early trials approach

Read more...

Recursion overhauls pipeline after key drug fails in mid-stage trial

Endpoints News - 05-May-2025

With $509M in cash, biotech bets on fewer, stronger programs ahead of 2025 data

Read more...

Biotech shake-up: Unity and Mammoth announce major layoffs amid strategic shifts

FierceBiotech - 05-May-2025

Unity exits eye drug race, Mammoth tightens focus on CRISPR pipeline

Read more...

Stately Bio emerges with AI-powered window into living cells

Endpoints News - 01-May-2025

AI startup decodes live cell behaviour using simple imaging and machine learning

Read more...

A brighter path for Parkinson’s: light therapy device nears FDA finish line

Longevity Technology - 28-Apr-2025

PhotoPharmics secures $6 million to advance its home-based Celeste device

Read more...

Catalytic antibodies lose their champion

Fight Aging! - 23-Apr-2025

Covalent Biosciences falters amid investor caution, patent expiry, and steep development costs

Read more...

Biolinq secures $100m to launch needle-free glucose monitor

FierceBiotech - 22-Apr-2025

Tracks glucose, activity, and sleep—offering a simpler option for people with Type 2 diabetes

Read more...

Breakthrough drug targets liver regeneration with 21.5m boost

Longevity Technology - 17-Apr-2025

HepaRegeniX advances trials for a novel liver regeneration therapy

Read more...

AI alliance to redefine the future of ageing and therapeutics

Juvenescence - 16-Apr-2025

M42 and Juvenescence join forces to accelerate precision medicine and longevity

Read more...

Science corp secures major funding to restore sight with BCI tech

Longevity Technology - 15-Apr-2025

A next-gen retinal implant offers new hope for vision loss from macular degeneration

Read more...

Switching genes, not sequences: the rise of epigenetic editing

Chemistry World - 09-Apr-2025

Precision drugs use chemical tags to control genes without changing DNA

Read more...

New drug for Parkinson’s may keep symptoms under control with just weekly injections

Longevity Technology - 09-Apr-2025

It avoids common delivery problems and enters Phase 1 trials in 2025

Read more...

China’s RiboX beats rivals to launch first circular RNA clinical trial

Endpoints News - 04-Apr-2025

A stealthy Shanghai startup pioneers a longer-lasting, safer alternative to mRNA and gene therapies

Read more...

Isomorphic Labs secures $600m to supercharge AI drug discovery

FierceBiotech - 31-Mar-2025

Backed by Nobel science, the Alphabet spinout speeds up AI drug development

Read more...

Tribune Therapeutics secures 37m to tackle fibrosis at its source

Longevity Technology - 28-Mar-2025

Scandinavian biotech targets fibrosis with novel scar-blocking therapies

Read more...

23andMe files for bankruptcy after data breach and financial struggles

BBC - 24-Mar-2025

Company is looking for a buyer, raising concerns about the security of customer DNA data

Read more...

Bit.bio cuts 25% of staff as it shifts from therapy development to lab research

FierceBiotech - 19-Mar-2025

Company aims to grow its product line and biotech partnerships

Read more...

Mito Health raised $4 million to grow its AI-powered health platform

Longevity Technology - 18-Mar-2025

It uses blood tests to find early health risks and gives personalised advice

Read more...

AstraZeneca bets $1 billion on revolutionary cancer therapy

The Guardian - 17-Mar-2025

AstraZeneca acquires EsoBiotec to revolutionize cell therapy with faster, more accessible treatments

Read more...

Augustine Therapeutics raises $84.8m for safer neuro and metabolic drugs

Longevity Technology - 12-Mar-2025

Clinical trials are beginning, backed by major investors like Novo Holdings

Read more...

Hinge Health is filing for an IPO after cutting losses and boosting revenue

Endpoints News - 10-Mar-2025

The IPO could mark a revival in digital health investments

Read more...

Scientists plan to reproduce groundbreaking rejuvenation experiment in rats

Live Forever Club - 06-Mar-2025

No donation too small to help extend Katcher's extracellular particles study

Read more...

Trimtech secures $31m to tackle neurodegenerative diseases

Longevity Technology - 06-Mar-2025

Targeted protein degradation tackles harmful aggregates while sparing healthy proteins

Read more...

Tenaya raises $52.5m to push forward gene therapy trials

Longevity Technology - 05-Mar-2025

The biotech firm accelerates clinical trials for TN-201 and TN-401, targeting genetic heart disease

Read more...

Jupiter Neurosciences partners with Aquanova to develop longevity products

GlobeNewswire - 04-Mar-2025

New collaboration aims to bring scientifically-backed solutions for ageing and healthspan

Read more...

AbbVie joins the obesity drug race with $2.2b Gubra deal

Endpoints News - 03-Mar-2025

The pharma giant bets on amylin therapy to enter the weight-loss market

Read more...

Bio-recell and AcouSort join forces to advance cell isolation

Bio-ReCell - 03-Mar-2025

The partnership merges acoustic tech with Revive™ SVF to boost stem cell purification

Read more...

Biograph: the elite longevity startup redefining preventive health

TechCrunch - 28-Feb-2025

Backed by Peter Attia, this startup uses advanced diagnostics to optimize lifespan

Read more...

Vertex ends gene editing deal with Verve amid R&D shift

FierceBiotech - 27-Feb-2025

Verve regains full rights to its liver disease program as it moves forward independently

Read more...

Bicycle Therapeutics eyes transformational growth in 2025

Business Weekly - 25-Feb-2025

With nearly $880 million in cash, Bicycle Therapeutics advances innovative cancer therapies

Read more...

Cyclarity Therapeutics advances series A tranche 2 funding to accelerate breakthrough cardiovascular treatment

Live Forever Club - 20-Feb-2025

Statins only slow down the progression of atherosclerosis – imagine if we could actually cure it!

Read more...

Maxwell Biosciences makes progress in infectious disease treatment

Live Forever Club - 19-Feb-2025

Investors are taking interest as the company moves toward human trials

Read more...

Bio-ReCell and BIOTEM collaborate to enhance T-cell therapy

Bio-ReCell - 19-Feb-2025

The partnership adds BIOTEM’s antibodies to Bio-ReCell’s kits to boost cell therapy precision and scale

Read more...

Subsense unveils non-surgical brain-computer interface with $17m boost

MassDevice - 18-Feb-2025

Nanoparticles power a new era of brain-computer interaction

Read more...

Europe’s first 100m consumer health fund targets proactive care revolution

Longevity Technology - 18-Feb-2025

naturalX backs startups reshaping wellness and prevention

Read more...

Mair Therapeutics targets Parkinson’s with AI-driven drug discovery

Longevity Technology - 17-Feb-2025

The Dutch startup is using ion channel research and advanced tech to develop new treatments

Read more...

VERIGRAFT secures 1.2m to revolutionize 3D-printed arterial grafts

Tech.eu - 14-Feb-2025

A Eurostars-backed project advancing personalized vascular grafts

Read more...

Junevity secures $10m to pioneer “cell reset” therapies for longevity

Longevity Technology - 13-Feb-2025

Backed by AI and genetics, Junevity targets age-related diseases

Read more...

Five Alarm Bio seeking funding to develop drugs targeting the chronic diseases of ageing

Live Forever Club - 12-Feb-2025

Promising preclinical results suggest a clear path towards drug development

Read more...

Nucleus brings whole-genome health testing to the masses

Longevity Technology - 30-Jan-2025

Cutting-edge DNA analysis provides affordable, real-time health insights

Read more...

The NAM catalyst award: Inspiring bold ideas for a healthier future in ageing

Live Forever Club - 27-Jan-2025

Winners receive $50,000 and global networking opportunities

Read more...

Neko Health secures $260m to revolutionize preventive care

Longevity Technology - 23-Jan-2025

Full-body scans drive early detection as Neko expands globally

Read more...

LinkGevity’s drug fights ageing and kidney disease, gains NASA’s support

Business Weekly - 23-Jan-2025

With backing from NASA and the Crick Institute, clinical trials are set to begin

Read more...

Arctic Therapeutics secures €26.5M to advance dementia drugs

Longevity Technology - 21-Jan-2025

Early trials show reduced stroke risks and slower progression

Read more...

Convergence Medical raises $3.1m for groundbreaking surgical robot

MassDevice - 21-Jan-2025

V01, the first arthroscopic robot, gains FDA breakthrough status and targets global growth

Read more...

Brain surgery reimagined: microrobots unlock new frontiers

Independent - 17-Jan-2025

Tiny robots tested in animals promise less invasive neurological treatments

Read more...

Roche taps Dyno Therapeutics' AI-driven capsids for neurological gene therapy

Genetic Engineering & Biotechnology News (GEN) - 15-Jan-2025

A partnership advancing synthetic AAV vectors to tackle gene therapy challenges

Read more...

AI startup raises $41M to build a universal biology research tool

Longevity Technology - 15-Jan-2025

Company aims to predict diseases, design therapies, and revolutionise research

Read more...

Nanomedicines to reduce invasive treatments for inflammatory diseases

Longevity Technology - 14-Jan-2025

It holds potential for treating inflammation, cancer, ageing, and autoimmunity

Read more...

Scaling innovation: Daewoong pioneers mass production of organoids

Korea Biomedical Review (KBR) - 13-Jan-2025

A national project aims to revolutionize regenerative medicine with advanced automation

Read more...

Tuning the future: epigenetic editing breaks new ground in genetic medicine

Endpoints News - 12-Jan-2025

Tune Therapeutics secures $175M to pioneer precise gene modulation therapies

Read more...

Tenvie Therapeutics raises major funding to tackle age-related diseases

Longevity Technology - 10-Jan-2025

Dual-action therapies tackling inflammation, metabolism, and neurodegeneration

Read more...

Patients Know Best secures funding to advance digital health records

Digital Health - 07-Jan-2025

Funding supports NHS digitalisation goals and global expansion of personal health record platform

Read more...

General Proximity uses biological proximity to develop new medicines

Longevity Technology - 06-Jan-2025

The company has raised $16 million from investors

Read more...

Nuritas raised $42M to expand AI-driven peptide discovery for sustainable solutions

Longevity Technology - 23-Dec-2024

Their platform speeds up finding peptides from plants, making healthcare solutions faster

Read more...

Revolutionizing healthy ageing: ARPA-H's bold new initiative

Advanced Research Projects Agency for Health (ARPA-H) - 19-Dec-2024

Extending healthspan and tackling age-related challenges with innovative therapies and technologies

Read more...

DeepLife secures $10M for AI-driven healthcare innovation using digital twins

Longevity Technology - 17-Dec-2024

This breakthrough combines large biological datasets and advanced AI tools

Read more...

Precision Neuroscience raised $102M, closing its Series C funding

MobiHealthNews - 16-Dec-2024

Company competes with Neuralink and Synchron to revolutionise AI-human integration

Read more...

Angitia secures $120m to tackle bone health challenges

Longevity Technology - 12-Dec-2024

Biotech firm advances osteoporosis therapies and strengthens leadership with key appointment

Read more...

LongGame invests in early-stage biotech startups targeting ageing and life extension

Longevity Technology - 12-Dec-2024

Focus areas include gene editing, stem cell therapies, and affordable health solutions

Read more...

Capstan Medical secures $110m to revolutionize heart valve repair with robotic technology

MobiHealthNews - 11-Dec-2024

Innovative robotic solutions aim to improve treatment for millions with heart valve disease

Read more...

Pioneering RNA therapies to transform heart disease treatment

King’s College London - 11-Dec-2024

A £50M centre unlocking heart regeneration with RNA therapies

Read more...

BioAge halts obesity drug trial after safety concerns

BioPharma Dive - 07-Dec-2024

Liver enzyme spikes in participants prompt a major setback for the biotech firm

Read more...

Jupiter Neurosciences raises $11M for a resveratrol-based Parkinson’s treatment

Longevity Technology - 05-Dec-2024

The treatment "JOTROL" shows promise in cognitive and brain health conditions

Read more...

Abselion raises 6.6 million to transform protein quantification

BGF - 05-Dec-2024

Investors back Amperia for faster, more accessible protein measurement

Read more...

Refoxy raises millions to advance FOXO3 ageing therapies

Longevity Technology - 04-Dec-2024

Pioneering treatments target underlying mechanisms of age-related diseases like pulmonary fibrosis

Read more...

Startup secures major funding to revolutionize chronic disease testing

Longevity Technology - 02-Dec-2024

Powered by AI, pocdoc accelerates early detection and treatment of chronic diseases

Read more...

Doron Therapeutics secures $11m to advance osteoarthritis drug

Longevity Technology - 29-Nov-2024

Breakthrough MOTYS moves to phase 3 trials, promising lasting relief for knee osteoarthritis

Read more...

Oura and Dexcom join forces to transform metabolic health

Longevity Technology - 21-Nov-2024

Integrated glucose monitoring and wearable insights offer a personalized approach to health tracking

Read more...

TRexBio raises $84M to develop immune therapies targeting inflammation

Longevity Technology - 20-Nov-2024

Funding strengthens their capacity to address unmet needs in immune-related diseases

Read more...